|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Market: Sweden
Espicom Business Intelligence Ltd, Sep 2009, Pages: 92
This in-depth pharmaceutical market report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Executive Summary
The pharmaceutical market in 2009 was estimated to be US$4.6 billion, equal to US$492 per capita. The pharmaceutical market represents approximately 12.0% of total healthcare expenditure and 1.2% of GDP.
The market is expected to increase at a rate of 4.2% per year at current prices over the next few years, to be worth in excess of US$6.8 billion by 2014.
However, Sweden is likely to be affected by the global economic downturn, with real GDP growth expected to fall to -3.5% in 2009, according to figures from the Economist Intelligence Unit, and beginning to recover in 2011 with a real growth of 1.3%, rising to 2.7% by 2014.
As is common with other Western European countries, Sweden has an advanced healthcare system which is partially privately funded. As a percentage of GDP, health expenditure is above the European average.
Domestic production is focused primarily on retail medicaments, accounting for 97% of total production in 2004. Total production increased by approximately 2.9% in 2004 over 2003, to reach US$6.6 billion, decreasing by 6.4% in local currency terms.
Apoteket AB is currently the exclusive pharmaceutical retailer in Sweden, to both public and hospital pharmacies. However, the pharmacy monopoly is soon to be deregulated, with the introduction of independent pharmacies from July 2009. Apoteket AB will remain a key competitor in the market, however, with around half of the pharmacies remaining under state ownership.
Customers who bought this item also bought
The Pharmaceutical Market: Mexico
The Pharmaceutical Market: Malaysia
The Pharmaceutical Market: USA
The Pharmaceutical Market: Greece
The Pharmaceutical Market: Russia
The Pharmaceutical Market: Ukraine
The Pharmaceutical Market: Switzerland
The Pharmaceutical Market: Portugal
The Pharmaceutical Market: Thailand
The Pharmaceutical Market: Argentina
The Pharmaceutical Market: Netherlands
The Pharmaceutical Market: New Zealand
|
|
|
|
